메뉴 건너뛰기




Volumn 20, Issue 35, 2014, Pages 12391-12406

Colorectal cancer with liver metastases: Neoadjuvant chemotherapy, surgical resection first or palliation alone?

Author keywords

Colorectal cancer; Colorectal liver metastases; Disappearing liver metastases; Neo adjuvant chemotherapy; Radiofrequency ablation; Surgical resection

Indexed keywords

BEVACIZUMAB; CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

EID: 84909581997     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i35.12391     Document Type: Review
Times cited : (48)

References (161)
  • 1
    • 84872967522 scopus 로고    scopus 로고
    • Cancer statistics, 2013
    • PMID: 23335087
    • Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013; 63: 11-30 [PMID: 23335087 DOI: 10.3322/caac.21166]
    • (2013) CA Cancer J Clin , vol.63 , pp. 11-30
    • Siegel, R.1    Naishadham, D.2    Jemal, A.3
  • 2
    • 78049485263 scopus 로고    scopus 로고
    • Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
    • PMID: 21351269
    • Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-2917 [PMID: 21351269 DOI: 10.1002/ijc.25516]
    • (2010) Int J Cancer , vol.127 , pp. 2893-2917
    • Ferlay, J.1    Shin, H.R.2    Bray, F.3    Forman, D.4    Mathers, C.5    Parkin, D.M.6
  • 3
    • 0037393449 scopus 로고    scopus 로고
    • Colorectal carcinoma: Diagnostic, prognostic, and molecular features
    • PMID: 12692203
    • Compton CC. Colorectal carcinoma: diagnostic, prognostic, and molecular features. Mod Pathol 2003; 16: 376-388 [PMID: 12692203 DOI: 10.1097/01.MP.0000062859.46942.93]
    • (2003) Mod Pathol , vol.16 , pp. 376-388
    • Compton, C.C.1
  • 4
    • 13744251436 scopus 로고    scopus 로고
    • Systemic therapy for colorectal cancer
    • PMID: 15689586
    • Meyerhardt JA, Mayer RJ. Systemic therapy for colorectal cancer. N Engl J Med 2005; 352: 476-487 [PMID: 15689586 DOI: 10.1056/NEJMra040958]
    • (2005) N Engl J Med , vol.352 , pp. 476-487
    • Meyerhardt, J.A.1    Mayer, R.J.2
  • 6
    • 55049130752 scopus 로고    scopus 로고
    • Innovations in chemotherapy for metastatic colorectal cancer: An update of recent clinical trials
    • PMID: 18922828
    • O'Neil BH, Goldberg RM. Innovations in chemotherapy for metastatic colorectal cancer: an update of recent clinical trials. Oncologist 2008; 13: 1074-1083 [PMID: 18922828 DOI: 10.1634/theoncologist.2008-0083]
    • (2008) Oncologist , vol.13 , pp. 1074-1083
    • O'Neil, B.H.1    Goldberg, R.M.2
  • 11
    • 3242889487 scopus 로고    scopus 로고
    • Epidemiology of colorectal cancer liver metastases
    • discussion 822-823 [PMID: 14979048]
    • Faivre J, Manfredi S, Bouvier AM. [Epidemiology of colorectal cancer liver metastases]. Bull Acad Natl Med 2003; 187: 815-822; discussion 822-823 [PMID: 14979048]
    • (2003) Bull Acad Natl Med , vol.187 , pp. 815-822
    • Faivre, J.1    Manfredi, S.2    Bouvier, A.M.3
  • 12
    • 83255192273 scopus 로고    scopus 로고
    • Trends in incidence, treatment and survival of patients with stage IV colorectal cancer: A population-based series
    • PMID: 21176063
    • van der Pool AE, Damhuis RA, Ijzermans JN, de Wilt JH, Eggermont AM, Kranse R, Verhoef C. Trends in incidence, treatment and survival of patients with stage IV colorectal cancer: a population-based series. Colorectal Dis 2012; 14: 56-61 [PMID: 21176063 DOI: 10.1111/j.1463-1318.2010.02539.x]
    • (2012) Colorectal Dis , vol.14 , pp. 56-61
    • Van Der Pool, A.E.1    Damhuis, R.A.2    Ijzermans, J.N.3    De Wilt, J.H.4    Eggermont, A.M.5    Kranse, R.6    Verhoef, C.7
  • 15
    • 62849091015 scopus 로고    scopus 로고
    • Is hepatic resection justified after chemotherapy in patients with colorectal liver metastases and lymph node involvement?
    • author reply 1345 [PMID: 19280684]
    • Adam R, Aloia TA. Is hepatic resection justified after chemotherapy in patients with colorectal liver metastases and lymph node involvement? J Clin Oncol 2009; 27: 1343-1345; author reply 1345 [PMID: 19280684]
    • (2009) J Clin Oncol , vol.27 , pp. 1343-1345
    • Adam, R.1    Aloia, T.A.2
  • 16
    • 23844448040 scopus 로고    scopus 로고
    • Neoadjuvant treatment of unresectable colorectal liver metastases: Correlation between tumour response and resection rates
    • PMID: 15870084
    • Folprecht G, Grothey A, Alberts S, Raab HR, Köhne CH. Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates. Ann Oncol 2005; 16: 1311-1319 [PMID: 15870084 DOI: 10.1093/annonc/mdi246]
    • (2005) Ann Oncol , vol.16 , pp. 1311-1319
    • Folprecht, G.1    Grothey, A.2    Alberts, S.3    Raab, H.R.4    Köhne, C.H.5
  • 17
    • 80855131559 scopus 로고    scopus 로고
    • Neoadjuvant therapy concepts for liver metastases
    • PMID: 22033894
    • Folprecht G, Bechstein WO. [Neoadjuvant therapy concepts for liver metastases]. Chirurg 2011; 82: 989-994 [PMID: 22033894 DOI: 10.1007/s00104-011-2131-7]
    • (2011) Chirurg , vol.82 , pp. 989-994
    • Folprecht, G.1    Bechstein, W.O.2
  • 20
    • 0029383554 scopus 로고
    • Recurrent tumor after R0 resection of colorectal liver metastases. Incidence, resectability and prognosis
    • PMID: 8529448
    • Scheele J, Stangl R, Schmidt K, Altendorf-Hofmann A. [Recurrent tumor after R0 resection of colorectal liver metastases. Incidence, resectability and prognosis]. Chirurg 1995; 66: 965-973 [PMID: 8529448]
    • (1995) Chirurg , vol.66 , pp. 965-973
    • Scheele, J.1    Stangl, R.2    Schmidt, K.3    Altendorf-Hofmann, A.4
  • 21
    • 0029881854 scopus 로고    scopus 로고
    • Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients
    • Association Franc¸aise de Chirurgie PMID: 8608500
    • Nordlinger B, Guiguet M, Vaillant JC, Balladur P, Boudjema K, Bachellier P, Jaeck D. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Franc¸aise de Chirurgie. Cancer 1996; 77: 1254-1262 [PMID: 8608500]
    • (1996) Cancer , vol.77 , pp. 1254-1262
    • Nordlinger, B.1    Guiguet, M.2    Vaillant, J.C.3    Balladur, P.4    Boudjema, K.5    Bachellier, P.6    Jaeck, D.7
  • 22
    • 0030973169 scopus 로고    scopus 로고
    • Hepatic resection for metastatic colorectal cancer results in cure for some patients
    • discussion 511 [PMID: 9161393]
    • Jamison RL, Donohue JH, Nagorney DM, Rosen CB, Harmsen WS, Ilstrup DM. Hepatic resection for metastatic colorectal cancer results in cure for some patients. Arch Surg 1997; 132: 505-510; discussion 511 [PMID: 9161393]
    • (1997) Arch Surg , vol.132 , pp. 505-510
    • Jamison, R.L.1    Donohue, J.H.2    Nagorney, D.M.3    Rosen, C.B.4    Harmsen, W.S.5    Ilstrup, D.M.6
  • 25
    • 2442704240 scopus 로고    scopus 로고
    • Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases
    • discussion 825-827 [PMID: 15166961]
    • Abdalla EK, Vauthey JN, Ellis LM, Ellis V, Pollock R, Broglio KR, Hess K, Curley SA. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004; 239: 818-825; discussion 825-827 [PMID: 15166961]
    • (2004) Ann Surg , vol.239 , pp. 818-825
    • Abdalla, E.K.1    Vauthey, J.N.2    Ellis, L.M.3    Ellis, V.4    Pollock, R.5    Broglio, K.R.6    Hess, K.7    Curley, S.A.8
  • 26
    • 33645873301 scopus 로고    scopus 로고
    • Survival after hepatic resection for colorectal metastases: A 10-year experience
    • PMID: 16523369
    • Wei AC, Greig PD, Grant D, Taylor B, Langer B, Gallinger S. Survival after hepatic resection for colorectal metastases: a 10-year experience. Ann Surg Oncol 2006; 13: 668-676 [PMID: 16523369 DOI: 10.1245/ASO.2006.05.039]
    • (2006) Ann Surg Oncol , vol.13 , pp. 668-676
    • Wei, A.C.1    Greig, P.D.2    Grant, D.3    Taylor, B.4    Langer, B.5    Gallinger, S.6
  • 27
    • 37549016003 scopus 로고    scopus 로고
    • Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: A multifactorial model of 929 patients
    • PMID: 18156932
    • Rees M, Tekkis PP, Welsh FK, O'Rourke T, John TG. Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg 2008; 247: 125-135 [PMID: 18156932 DOI: 10.1097/SLA.0b013e31815aa2c2]
    • (2008) Ann Surg , vol.247 , pp. 125-135
    • Rees, M.1    Tekkis, P.P.2    Welsh, F.K.3    O'Rourke, T.4    John, T.G.5
  • 28
    • 70249110476 scopus 로고    scopus 로고
    • Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: An international multi-institutional analysis of 1669 patients
    • PMID: 19730175
    • de Jong MC, Pulitano C, Ribero D, Strub J, Mentha G, Schulick RD, Choti MA, Aldrighetti L, Capussotti L, Pawlik TM. Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients. Ann Surg 2009; 250: 440-448 [PMID: 19730175 DOI: 10.1097/SLA.0b013e3181b4539b]
    • (2009) Ann Surg , vol.250 , pp. 440-448
    • De Jong, M.C.1    Pulitano, C.2    Ribero, D.3    Strub, J.4    Mentha, G.5    Schulick, R.D.6    Choti, M.A.7    Aldrighetti, L.8    Capussotti, L.9    Pawlik, T.M.10
  • 30
    • 4344615981 scopus 로고    scopus 로고
    • Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET)
    • discussion 447-450 [PMID: 15319715]
    • Fernandez FG, Drebin JA, Linehan DC, Dehdashti F, Siegel BA, Strasberg SM. Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg 2004; 240: 438-447; discussion 447-450 [PMID: 15319715]
    • (2004) Ann Surg , vol.240 , pp. 438-447
    • Fernandez, F.G.1    Drebin, J.A.2    Linehan, D.C.3    Dehdashti, F.4    Siegel, B.A.5    Strasberg, S.M.6
  • 31
    • 33846939792 scopus 로고    scopus 로고
    • Survival after hepatic resection in metastatic colorectal cancer: A population-based study
    • PMID: 17238180
    • Cummings LC, Payes JD, Cooper GS. Survival after hepatic resection in metastatic colorectal cancer: a population-based study. Cancer 2007; 109: 718-726 [PMID: 17238180 DOI: 10.1002/cncr.22448]
    • (2007) Cancer , vol.109 , pp. 718-726
    • Cummings, L.C.1    Payes, J.D.2    Cooper, G.S.3
  • 33
    • 0033504042 scopus 로고    scopus 로고
    • Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases
    • discussion 318-321 [PMID: 10493478]
    • Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999; 230: 309-318; discussion 318-321 [PMID: 10493478]
    • (1999) Ann Surg , vol.230 , pp. 309-318
    • Fong, Y.1    Fortner, J.2    Sun, R.L.3    Brennan, M.F.4    Blumgart, L.H.5
  • 34
    • 78650668890 scopus 로고    scopus 로고
    • Use of clinical score to stage and predict outcome of hepatic resection of metastatic colorectal cancer
    • PMID: 21165993
    • Feroci F, Fong Y. Use of clinical score to stage and predict outcome of hepatic resection of metastatic colorectal cancer. J Surg Oncol 2010; 102: 914-921 [PMID: 21165993 DOI: 10.1002/jso.21715]
    • (2010) J Surg Oncol , vol.102 , pp. 914-921
    • Feroci, F.1    Fong, Y.2
  • 35
    • 84855758951 scopus 로고    scopus 로고
    • Improving the clinical risk score: An analysis of molecular biomarkers in the era of modern chemotherapy for resectable hepatic colorectal cancer metastases
    • PMID: 21982065
    • Maithel SK, Gönen M, Ito H, Dematteo RP, Allen PJ, Fong Y, Blumgart LH, Jarnagin WR, D'Angelica MI. Improving the clinical risk score: an analysis of molecular biomarkers in the era of modern chemotherapy for resectable hepatic colorectal cancer metastases. Surgery 2012; 151: 162-170 [PMID: 21982065 DOI: 10.1016/j.surg.2011.07.020]
    • (2012) Surgery , vol.151 , pp. 162-170
    • Maithel, S.K.1    Gönen, M.2    Ito, H.3    Dematteo, R.P.4    Allen, P.J.5    Fong, Y.6    Blumgart, L.H.7    Jarnagin, W.R.8    D'Angelica, M.I.9
  • 36
    • 41549103291 scopus 로고    scopus 로고
    • A new classification system for liver metastases from colorectal cancer in Japanese multicenter analysis
    • PMID: 18507101
    • Yamaguchi T, Mori T, Takahashi K, Matsumoto H, Miyamoto H, Kato T. A new classification system for liver metastases from colorectal cancer in Japanese multicenter analysis. Hepatogastroenterology 2008; 55: 173-178 [PMID: 18507101]
    • (2008) Hepatogastroenterology , vol.55 , pp. 173-178
    • Yamaguchi, T.1    Mori, T.2    Takahashi, K.3    Matsumoto, H.4    Miyamoto, H.5    Kato, T.6
  • 38
    • 0034059484 scopus 로고    scopus 로고
    • Survival after resection of multiple bilobar hepatic metastases from colorectal carcinoma
    • PMID: 10767796
    • Bolton JS, Fuhrman GM. Survival after resection of multiple bilobar hepatic metastases from colorectal carcinoma. Ann Surg 2000; 231: 743-751 [PMID: 10767796]
    • (2000) Ann Surg , vol.231 , pp. 743-751
    • Bolton, J.S.1    Fuhrman, G.M.2
  • 39
  • 40
    • 31944447155 scopus 로고    scopus 로고
    • Debunking dogma: Surgery for four or more colorectal liver metastases is justified
    • PMID: 16455457
    • Pawlik TM, Abdalla EK, Ellis LM, Vauthey JN, Curley SA. Debunking dogma: surgery for four or more colorectal liver metastases is justified. J Gastrointest Surg 2006; 10: 240-248 [PMID: 16455457 DOI: 10.1016/j.gassur.2005.07.027]
    • (2006) J Gastrointest Surg , vol.10 , pp. 240-248
    • Pawlik, T.M.1    Abdalla, E.K.2    Ellis, L.M.3    Vauthey, J.N.4    Curley, S.A.5
  • 41
    • 34250173120 scopus 로고    scopus 로고
    • Outcome after hepatectomy for multiple (four or more) colorectal metastases in the era of effective chemotherapy
    • PMID: 17195913
    • Kornprat P, Jarnagin WR, Gonen M, DeMatteo RP, Fong Y, Blumgart LH, D'Angelica M. Outcome after hepatectomy for multiple (four or more) colorectal metastases in the era of effective chemotherapy. Ann Surg Oncol 2007; 14: 1151-1160 [PMID: 17195913 DOI: 10.1245/s10434-006-9068-y]
    • (2007) Ann Surg Oncol , vol.14 , pp. 1151-1160
    • Kornprat, P.1    Jarnagin, W.R.2    Gonen, M.3    DeMatteo, R.P.4    Fong, Y.5    Blumgart, L.H.6    D'Angelica, M.7
  • 42
    • 79952753550 scopus 로고    scopus 로고
    • High survival rate after two-stage resection of advanced colorectal liver metastases: Response-based selection and complete resection define outcome
    • PMID: 21263087
    • Brouquet A, Abdalla EK, Kopetz S, Garrett CR, Overman MJ, Eng C, Andreou A, Loyer EM, Madoff DC, Curley SA, Vauthey JN. High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome. J Clin Oncol 2011; 29: 1083-1090 [PMID: 21263087 DOI: 10.1200/JCO.2010.32.6132]
    • (2011) J Clin Oncol , vol.29 , pp. 1083-1090
    • Brouquet, A.1    Abdalla, E.K.2    Kopetz, S.3    Garrett, C.R.4    Overman, M.J.5    Eng, C.6    Andreou, A.7    Loyer, E.M.8    Madoff, D.C.9    Curley, S.A.10    Vauthey, J.N.11
  • 44
    • 67649204238 scopus 로고    scopus 로고
    • Long-term survival after liver resection for colorectal liver metastases in patients with hepatic pedicle lymph nodes involvement in the era of new chemotherapy regimens
    • PMID: 19474695
    • Oussoultzoglou E, Romain B, Panaro F, Rosso E, Pessaux P, Bachellier P, Jaeck D. Long-term survival after liver resection for colorectal liver metastases in patients with hepatic pedicle lymph nodes involvement in the era of new chemotherapy regimens. Ann Surg 2009; 249: 879-886 [PMID: 19474695 DOI: 10.1097/SLA.0b013e3181a334d9]
    • (2009) Ann Surg , vol.249 , pp. 879-886
    • Oussoultzoglou, E.1    Romain, B.2    Panaro, F.3    Rosso, E.4    Pessaux, P.5    Bachellier, P.6    Jaeck, D.7
  • 46
    • 77951667439 scopus 로고    scopus 로고
    • Cohort study of the survival benefit of resection for recurrent hepatic and/or pulmonary metastases after primary hepatectomy for colorectal metastases
    • PMID: 20395862
    • Mise Y, Imamura H, Hashimoto T, Seyama Y, Aoki T, Hasegawa K, Beck Y, Sugawara Y, Makuuchi M, Nakajima J, Kokudo N. Cohort study of the survival benefit of resection for recurrent hepatic and/or pulmonary metastases after primary hepatectomy for colorectal metastases. Ann Surg 2010; 251: 902-909 [PMID: 20395862 DOI: 10.1097/SLA.0b013e3181c9868a]
    • (2010) Ann Surg , vol.251 , pp. 902-909
    • Mise, Y.1    Imamura, H.2    Hashimoto, T.3    Seyama, Y.4    Aoki, T.5    Hasegawa, K.6    Beck, Y.7    Sugawara, Y.8    Makuuchi, M.9    Nakajima, J.10    Kokudo, N.11
  • 47
    • 84874622311 scopus 로고    scopus 로고
    • Risk factors for survival after lung metastasectomy in colorectal cancer patients: A systematic review and meta-analysis
    • PMID: 23104709
    • Gonzalez M, Poncet A, Combescure C, Robert J, Ris HB, Gervaz P. Risk factors for survival after lung metastasectomy in colorectal cancer patients: a systematic review and meta-analysis. Ann Surg Oncol 2013; 20: 572-579 [PMID: 23104709 DOI: 10.1245/s10434-012-2726-3]
    • (2013) Ann Surg Oncol , vol.20 , pp. 572-579
    • Gonzalez, M.1    Poncet, A.2    Combescure, C.3    Robert, J.4    Ris, H.B.5    Gervaz, P.6
  • 49
    • 78649643868 scopus 로고    scopus 로고
    • Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: A meta-analysis of prospective studies including patients who have not previously undergone treatment
    • PMID: 20829538
    • Niekel MC, Bipat S, Stoker J. Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment. Radiology 2010; 257: 674-684 [PMID: 20829538 DOI: 10.1148/radiol.10100729]
    • (2010) Radiology , vol.257 , pp. 674-684
    • Niekel, M.C.1    Bipat, S.2    Stoker, J.3
  • 50
    • 33947654364 scopus 로고    scopus 로고
    • Predicting response of colorectal hepatic metastasis: Value of pretreatment apparent diffusion coefficients
    • PMID: 17377036
    • Koh DM, Scurr E, Collins D, Kanber B, Norman A, Leach MO, Husband JE. Predicting response of colorectal hepatic metastasis: value of pretreatment apparent diffusion coefficients. AJR Am J Roentgenol 2007; 188: 1001-1008 [PMID: 17377036 DOI: 10.2214/AJR.06.0601]
    • (2007) AJR Am J Roentgenol , vol.188 , pp. 1001-1008
    • Koh, D.M.1    Scurr, E.2    Collins, D.3    Kanber, B.4    Norman, A.5    Leach, M.O.6    Husband, J.E.7
  • 51
    • 51549112352 scopus 로고    scopus 로고
    • Apparent diffusion coefficient: Potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastases
    • PMID: 18710982
    • Cui Y, Zhang XP, Sun YS, Tang L, Shen L. Apparent diffusion coefficient: potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastases. Radiology 2008; 248: 894-900 [PMID: 18710982 DOI: 10.1148/radiol.2483071407]
    • (2008) Radiology , vol.248 , pp. 894-900
    • Cui, Y.1    Zhang, X.P.2    Sun, Y.S.3    Tang, L.4    Shen, L.5
  • 52
    • 84884565275 scopus 로고    scopus 로고
    • The role of pre-treatment diffusion-weighted MRI in predicting long-term outcome of colorectal liver metastasis
    • PMID: 23995873
    • Tam HH, Collins DJ, Brown G, Chau I, Cunningham D, Leach MO, Koh DM. The role of pre-treatment diffusion-weighted MRI in predicting long-term outcome of colorectal liver metastasis. Br J Radiol 2013; 86: 20130281 [PMID: 23995873 DOI: 10.1259/bjr.20130281]
    • (2013) Br J Radiol , vol.86 , pp. 20130281
    • Tam, H.H.1    Collins, D.J.2    Brown, G.3    Chau, I.4    Cunningham, D.5    Leach, M.O.6    Koh, D.M.7
  • 53
    • 29144504049 scopus 로고    scopus 로고
    • The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases
    • PMID: 16315241
    • Wiering B, Krabbe PF, Jager GJ, Oyen WJ, Ruers TJ. The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases. Cancer 2005; 104: 2658-2670 [PMID: 16315241 DOI: 10.1002/cncr.21569]
    • (2005) Cancer , vol.104 , pp. 2658-2670
    • Wiering, B.1    Krabbe, P.F.2    Jager, G.J.3    Oyen, W.J.4    Ruers, T.J.5
  • 54
    • 83555175979 scopus 로고    scopus 로고
    • The role of 18FDG PET/CT in the management of colorectal liver metastases
    • PMID: 22151447
    • Engledow AH, Skipworth JR, Pakzad F, Imber C, Ell PJ, Groves AM. The role of 18FDG PET/CT in the management of colorectal liver metastases. HPB (Oxford) 2012; 14: 20-25 [PMID: 22151447 DOI: 10.1111/j.1477-2574.2011.00378.x]
    • (2012) HPB (Oxford) , vol.14 , pp. 20-25
    • Engledow, A.H.1    Skipworth, J.R.2    Pakzad, F.3    Imber, C.4    Ell, P.J.5    Groves, A.M.6
  • 55
    • 84879840955 scopus 로고    scopus 로고
    • Perioperative chemotherapy for resectable colorectal liver metastases
    • PMID: 23726258
    • Jones RP, Malik HZ, Fenwick SW, Poston GJ. Perioperative chemotherapy for resectable colorectal liver metastases: where now? Eur J Surg Oncol 2013; 39: 807-811 [PMID: 23726258 DOI: 10.1016/j.ejso.2013.04.002]
    • (2013) Where Now? Eur J Surg Oncol , vol.39 , pp. 807-811
    • Jones, R.P.1    Malik, H.Z.2    Fenwick, S.W.3    Poston, G.J.4
  • 57
    • 84907020985 scopus 로고    scopus 로고
    • Effect of neoadjuvant chemotherapy in patients with resectable colorectal liver metastases
    • PMID: 24466143
    • Zhu D, Zhong Y, Wei Y, Ye L, Lin Q, Ren L, Ye Q, Liu T, Xu J, Qin X. Effect of neoadjuvant chemotherapy in patients with resectable colorectal liver metastases. PLoS One 2014; 9: e86543 [PMID: 24466143 DOI: 10.1371/journal.pone.0086543]
    • (2014) PLoS One , vol.9 , pp. e86543
    • Zhu, D.1    Zhong, Y.2    Wei, Y.3    Ye, L.4    Lin, Q.5    Ren, L.6    Ye, Q.7    Liu, T.8    Xu, J.9    Qin, X.10
  • 58
    • 0346347411 scopus 로고    scopus 로고
    • Liver metastases - Primary or multimodal therapy?
    • PMID: 11554132
    • Ott R, Wein A, Hohenberger W. [Liver metastases - primary or multimodal therapy?]. Chirurg 2001; 72: 887-897 [PMID: 11554132]
    • (2001) Chirurg , vol.72 , pp. 887-897
    • Ott, R.1    Wein, A.2    Hohenberger, W.3
  • 60
    • 35348905517 scopus 로고    scopus 로고
    • Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases
    • PMID: 17895897
    • Barone C, Nuzzo G, Cassano A, Basso M, Schinzari G, Giuliante F, D'Argento E, Trigila N, Astone A, Pozzo C. Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases. Br J Cancer 2007; 97: 1035-1039 [PMID: 17895897 DOI: 10.1038/sj.bjc.6603988]
    • (2007) Br J Cancer , vol.97 , pp. 1035-1039
    • Barone, C.1    Nuzzo, G.2    Cassano, A.3    Basso, M.4    Schinzari, G.5    Giuliante, F.6    D'Argento, E.7    Trigila, N.8    Astone, A.9    Pozzo, C.10
  • 62
    • 84880736194 scopus 로고    scopus 로고
    • Randomized controlled trial of cetuximab plus chemotherapy for patients with KRAS wildtype unresectable colorectal liver-limited metastases
    • PMID: 23569301
    • Ye LC, Liu TS, Ren L, Wei Y, Zhu DX, Zai SY, Ye QH, Yu Y, Xu B, Qin XY, Xu J. Randomized controlled trial of cetuximab plus chemotherapy for patients with KRAS wildtype unresectable colorectal liver-limited metastases. J Clin Oncol 2013; 31: 1931-1938 [PMID: 23569301 DOI: 10.1200/JCO.2012.44.8308]
    • (2013) J Clin Oncol , vol.31 , pp. 1931-1938
    • Ye, L.C.1    Liu, T.S.2    Ren, L.3    Wei, Y.4    Zhu, D.X.5    Zai, S.Y.6    Ye, Q.H.7    Yu, Y.8    Xu, B.9    Qin, X.Y.10    Xu, J.11
  • 70
    • 0026012928 scopus 로고
    • Resection of synchronous liver metastases from colorectal cancer
    • PMID: 1994607
    • Vogt P, Raab R, Ringe B, Pichlmayr R. Resection of synchronous liver metastases from colorectal cancer. World J Surg 1991; 15: 62-67 [PMID: 1994607]
    • (1991) World J Surg , vol.15 , pp. 62-67
    • Vogt, P.1    Raab, R.2    Ringe, B.3    Pichlmayr, R.4
  • 71
    • 10644289883 scopus 로고    scopus 로고
    • Interval hepatic resection of colorectal metastases improves patient selection∗
    • PMID: 11064085
    • Lambert LA, Colacchio TA, Barth RJ. Interval hepatic resection of colorectal metastases improves patient selection∗. Curr Surg 2000; 57: 504 [PMID: 11064085]
    • (2000) Curr Surg , vol.57 , pp. 504
    • Lambert, L.A.1    Colacchio, T.A.2    Barth, R.J.3
  • 72
    • 84879307821 scopus 로고    scopus 로고
    • Systemic treatment of liver metastases from colorectal cancer
    • PMID: 23634197
    • Stein A, Schmoll HJ. Systemic treatment of liver metastases from colorectal cancer. Ther Adv Med Oncol 2013; 5: 193-203 [PMID: 23634197 DOI: 10.1177/1758834012473347]
    • (2013) Ther Adv Med Oncol , vol.5 , pp. 193-203
    • Stein, A.1    Schmoll, H.J.2
  • 74
    • 35348854952 scopus 로고    scopus 로고
    • Outcome of posthepatectomy-missing colorectal liver metastases after complete response to chemotherapy: Impact of adjuvant intra-arterial hepatic oxaliplatin
    • PMID: 17705091
    • Elias D, Goere D, Boige V, Kohneh-Sharhi N, Malka D, Tomasic G, Dromain C, Ducreux M. Outcome of posthepatectomy-missing colorectal liver metastases after complete response to chemotherapy: impact of adjuvant intra-arterial hepatic oxaliplatin. Ann Surg Oncol 2007; 14: 3188-3194 [PMID: 17705091 DOI: 10.1245/s10434-007-9482-9]
    • (2007) Ann Surg Oncol , vol.14 , pp. 3188-3194
    • Elias, D.1    Goere, D.2    Boige, V.3    Kohneh-Sharhi, N.4    Malka, D.5    Tomasic, G.6    Dromain, C.7    Ducreux, M.8
  • 76
    • 73449131515 scopus 로고    scopus 로고
    • Importance of complete pathologic response to prehepatectomy chemotherapy in treating colorectal cancer metastases
    • PMID: 19953712
    • Tanaka K, Takakura H, Takeda K, Matsuo K, Nagano Y, Endo I. Importance of complete pathologic response to prehepatectomy chemotherapy in treating colorectal cancer metastases. Ann Surg 2009; 250: 935-942 [PMID: 19953712]
    • (2009) Ann Surg , vol.250 , pp. 935-942
    • Tanaka, K.1    Takakura, H.2    Takeda, K.3    Matsuo, K.4    Nagano, Y.5    Endo, I.6
  • 78
    • 77956166838 scopus 로고    scopus 로고
    • Management of disappearing colorectal hepatic metastases
    • PMID: 20919526
    • Carpenter S, Fong Y. Management of disappearing colorectal hepatic metastases. Adv Surg 2010; 44: 269-279 [PMID: 20919526]
    • (2010) Adv Surg , vol.44 , pp. 269-279
    • Carpenter, S.1    Fong, Y.2
  • 79
    • 77958496525 scopus 로고    scopus 로고
    • Disappearing colorectal liver metastases after chemotherapy: Should we be concerned?
    • PMID: 20839072
    • van Vledder MG, de Jong MC, Pawlik TM, Schulick RD, Diaz LA, Choti MA. Disappearing colorectal liver metastases after chemotherapy: should we be concerned? J Gastrointest Surg 2010; 14: 1691-1700 [PMID: 20839072 DOI: 10.1007/s11605-010-1348-y]
    • (2010) J Gastrointest Surg , vol.14 , pp. 1691-1700
    • Van Vledder, M.G.1    De Jong, M.C.2    Pawlik, T.M.3    Schulick, R.D.4    Diaz, L.A.5    Choti, M.A.6
  • 80
    • 84866067714 scopus 로고    scopus 로고
    • Outcome in disappearing colorectal cancer liver metastases during oxaliplatin-based chemotherapy
    • PMID: 23162620
    • Ono T, Ishida H, Kumamoto K, Okada N, Ishibashi K. Outcome in disappearing colorectal cancer liver metastases during oxaliplatin-based chemotherapy. Oncol Lett 2012; 4: 905-909 [PMID: 23162620 DOI: 10.3892/ol.2012.842]
    • (2012) Oncol Lett , vol.4 , pp. 905-909
    • Ono, T.1    Ishida, H.2    Kumamoto, K.3    Okada, N.4    Ishibashi, K.5
  • 81
    • 84858705382 scopus 로고    scopus 로고
    • Intraoperative detection of disappearing colorectal liver metastases as a predictor of residual disease
    • PMID: 22258869
    • Ferrero A, Langella S, Russolillo N, Vigano' L, Lo Tesoriere R, Capussotti L. Intraoperative detection of disappearing colorectal liver metastases as a predictor of residual disease. J Gastrointest Surg 2012; 16: 806-814 [PMID: 22258869 DOI: 10.1007/s11605-011-1810-5]
    • (2012) J Gastrointest Surg , vol.16 , pp. 806-814
    • Ferrero, A.1    Langella, S.2    Russolillo, N.3    Vigano, L.4    Lo Tesoriere, R.5    Capussotti, L.6
  • 82
    • 79955618076 scopus 로고    scopus 로고
    • Complete radiological response of colorectal liver metastases after chemotherapy: What can we expect?
    • PMID: 21540596
    • Gaujoux S, Goéré D, Dumont F, Souadka A, Dromain C, Ducreux M, Elias D. Complete radiological response of colorectal liver metastases after chemotherapy: what can we expect? Dig Surg 2011; 28: 114-120 [PMID: 21540596 DOI: 10.1159/000323819]
    • (2011) Dig Surg , vol.28 , pp. 114-120
    • Gaujoux, S.1    Goéré, D.2    Dumont, F.3    Souadka, A.4    Dromain, C.5    Ducreux, M.6    Elias, D.7
  • 83
    • 84883487245 scopus 로고    scopus 로고
    • Surgical management of disappearing colorectal liver metastases
    • PMID: 24037559
    • Bischof DA, Clary BM, Maithel SK, Pawlik TM. Surgical management of disappearing colorectal liver metastases. Br J Surg 2013; 100: 1414-1420 [PMID: 24037559 DOI: 10.1002/bjs.9213]
    • (2013) Br J Surg , vol.100 , pp. 1414-1420
    • Bischof, D.A.1    Clary, B.M.2    Maithel, S.K.3    Pawlik, T.M.4
  • 84
    • 66149155832 scopus 로고    scopus 로고
    • Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: Recommendations from an expert panel
    • PMID: 19153115
    • Nordlinger B, Van Cutsem E, Gruenberger T, Glimelius B, Poston G, Rougier P, Sobrero A, Ychou M. Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel. Ann Oncol 2009; 20: 985-992 [PMID: 19153115 DOI: 10.1093/annonc/mdn735]
    • (2009) Ann Oncol , vol.20 , pp. 985-992
    • Nordlinger, B.1    Van Cutsem, E.2    Gruenberger, T.3    Glimelius, B.4    Poston, G.5    Rougier, P.6    Sobrero, A.7    Ychou, M.8
  • 86
    • 37549068554 scopus 로고    scopus 로고
    • Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy
    • PMID: 18156931
    • Nakano H, Oussoultzoglou E, Rosso E, Casnedi S, Chenard-Neu MP, Dufour P, Bachellier P, Jaeck D. Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy. Ann Surg 2008; 247: 118-124 [PMID: 18156931 DOI: 10.1097/SLA.0b013e31815774de]
    • (2008) Ann Surg , vol.247 , pp. 118-124
    • Nakano, H.1    Oussoultzoglou, E.2    Rosso, E.3    Casnedi, S.4    Chenard-Neu, M.P.5    Dufour, P.6    Bachellier, P.7    Jaeck, D.8
  • 87
    • 42949130734 scopus 로고    scopus 로고
    • Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer
    • PMID: 18398148
    • Gruenberger B, Tamandl D, Schueller J, Scheithauer W, Zielinski C, Herbst F, Gruenberger T. Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer. J Clin Oncol 2008; 26: 1830-1835 [PMID: 18398148 DOI: 10.1200/JCO.2007.13.7679]
    • (2008) J Clin Oncol , vol.26 , pp. 1830-1835
    • Gruenberger, B.1    Tamandl, D.2    Schueller, J.3    Scheithauer, W.4    Zielinski, C.5    Herbst, F.6    Gruenberger, T.7
  • 88
    • 84876484196 scopus 로고    scopus 로고
    • Chemotherapy-associated liver injury in patients with colorectal liver metastases: A systematic review and meta-analysis
    • PMID: 22766981
    • Robinson SM, Wilson CH, Burt AD, Manas DM, White SA. Chemotherapy-associated liver injury in patients with colorectal liver metastases: a systematic review and meta-analysis. Ann Surg Oncol 2012; 19: 4287-4299 [PMID: 22766981 DOI: 10.1245/s10434-012-2438-8]
    • (2012) Ann Surg Oncol , vol.19 , pp. 4287-4299
    • Robinson, S.M.1    Wilson, C.H.2    Burt, A.D.3    Manas, D.M.4    White, S.A.5
  • 89
    • 84868342910 scopus 로고    scopus 로고
    • Effect of bevacizumab added preoperatively to oxaliplatin on liver injury and complications after resection of colorectal liver metastases
    • PMID: 22552819
    • van der Pool AE, Marsman HA, Verheij J, Ten Kate FJ, Eggermont AM, Ijzermans JN, Verhoef C. Effect of bevacizumab added preoperatively to oxaliplatin on liver injury and complications after resection of colorectal liver metastases. J Surg Oncol 2012; 106: 892-897 [PMID: 22552819 DOI: 10.1002/jso.23142]
    • (2012) J Surg Oncol , vol.106 , pp. 892-897
    • Van Der Pool, A.E.1    Marsman, H.A.2    Verheij, J.3    Ten Kate, F.J.4    Eggermont, A.M.5    Ijzermans, J.N.6    Verhoef, C.7
  • 90
    • 37048998995 scopus 로고    scopus 로고
    • Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases
    • PMID: 17960603
    • Ribero D, Wang H, Donadon M, Zorzi D, Thomas MB, Eng C, Chang DZ, Curley SA, Abdalla EK, Ellis LM, Vauthey JN. Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases. Cancer 2007; 110: 2761-2767 [PMID: 17960603 DOI: 10.1002/cncr.23099]
    • (2007) Cancer , vol.110 , pp. 2761-2767
    • Ribero, D.1    Wang, H.2    Donadon, M.3    Zorzi, D.4    Thomas, M.B.5    Eng, C.6    Chang, D.Z.7    Curley, S.A.8    Abdalla, E.K.9    Ellis, L.M.10    Vauthey, J.N.11
  • 92
    • 33750962938 scopus 로고    scopus 로고
    • Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial
    • PMID: 17075115
    • Portier G, Elias D, Bouche O, Rougier P, Bosset JF, Saric J, Belghiti J, Piedbois P, Guimbaud R, Nordlinger B, Bugat R, Lazorthes F, Bedenne L. Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial. J Clin Oncol 2006; 24: 4976-4982 [PMID: 17075115 DOI: 10.1200/JCO.2006.06.8353]
    • (2006) J Clin Oncol , vol.24 , pp. 4976-4982
    • Portier, G.1    Elias, D.2    Bouche, O.3    Rougier, P.4    Bosset, J.F.5    Saric, J.6    Belghiti, J.7    Piedbois, P.8    Guimbaud, R.9    Nordlinger, B.10    Bugat, R.11    Lazorthes, F.12    Bedenne, L.13
  • 93
    • 70449105423 scopus 로고    scopus 로고
    • A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer
    • PMID: 19567451
    • Ychou M, Hohenberger W, Thezenas S, Navarro M, Maurel J, Bokemeyer C, Shacham-Shmueli E, Rivera F, Kwok-Keung Choi C, Santoro A. A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer. Ann Oncol 2009; 20: 1964-1970 [PMID: 19567451 DOI: 10.1093/annonc/mdp236]
    • (2009) Ann Oncol , vol.20 , pp. 1964-1970
    • Ychou, M.1    Hohenberger, W.2    Thezenas, S.3    Navarro, M.4    Maurel, J.5    Bokemeyer, C.6    Shacham-Shmueli, E.7    Rivera, F.8    Kwok-Keung Choi, C.9    Santoro, A.10
  • 96
    • 34548160680 scopus 로고    scopus 로고
    • Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: Results of CALGB 89803
    • PMID: 17687149
    • Saltz LB, Niedzwiecki D, Hollis D, Goldberg RM, Hantel A, Thomas JP, Fields AL, Mayer RJ. Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: results of CALGB 89803. J Clin Oncol 2007; 25: 3456-3461 [PMID: 17687149 DOI: 10.1200/JCO.2007.11.2144]
    • (2007) J Clin Oncol , vol.25 , pp. 3456-3461
    • Saltz, L.B.1    Niedzwiecki, D.2    Hollis, D.3    Goldberg, R.M.4    Hantel, A.5    Thomas, J.P.6    Fields, A.L.7    Mayer, R.J.8
  • 99
    • 79954441911 scopus 로고    scopus 로고
    • Final results of the EORTC intergroup randomized study 40004 (CLOCC) evaluating the benefit of radiofrequency ablation (RFA) combined with chemotherapy for unresectable colorectal liver metastases (CRC LM)
    • ASCO. Chicago 2010
    • Ruers TPC, Coevorden F, Rinkes B, Ledermann G, Poston G, Bechstein W, Lentz M, Nordlinger B. Final results of the EORTC intergroup randomized study 40004 (CLOCC) evaluating the benefit of radiofrequency ablation (RFA) combined with chemotherapy for unresectable colorectal liver metastases (CRC LM). ASCO. Chicago 2010. J Clin Oncol 2010; 28 (suppl; abstr 3526): 15s
    • (2010) J Clin Oncol , vol.28 , pp. 15s
    • Ruers, T.P.C.1    Coevorden, F.2    Rinkes, B.3    Ledermann, G.4    Poston, G.5    Bechstein, W.6    Lentz, M.7    Nordlinger, B.8
  • 100
    • 84875109240 scopus 로고    scopus 로고
    • Radiofrequency ablation of liver metastases from colorectal cancer: A literature review
    • PMID: 23422905
    • Minami Y, Kudo M. Radiofrequency ablation of liver metastases from colorectal cancer: a literature review. Gut Liver 2013; 7: 1-6 [PMID: 23422905 DOI: 10.5009/gnl.2013.7.1.1]
    • (2013) Gut Liver , vol.7 , pp. 1-6
    • Minami, Y.1    Kudo, M.2
  • 101
    • 38049152698 scopus 로고    scopus 로고
    • Radiofrequency ablation for metachronous liver metastasis from colorectal cancer after curative surgery
    • PMID: 17882491
    • Park IJ, Kim HC, Yu CS, Kim PN, Won HJ, Kim JC. Radiofrequency ablation for metachronous liver metastasis from colorectal cancer after curative surgery. Ann Surg Oncol 2008; 15: 227-232 [PMID: 17882491 DOI: 10.1245/s10434-007-9625-z]
    • (2008) Ann Surg Oncol , vol.15 , pp. 227-232
    • Park, I.J.1    Kim, H.C.2    Yu, C.S.3    Kim, P.N.4    Won, H.J.5    Kim, J.C.6
  • 104
    • 0033036765 scopus 로고    scopus 로고
    • Is carcino-embryonic antigen useful in the follow-up management of patients with colorectal liver metastases?
    • PMID: 10037299
    • Bakalakos EA, Burak WE, Young DC, Martin EW. Is carcino-embryonic antigen useful in the follow-up management of patients with colorectal liver metastases? Am J Surg 1999; 177: 2-6 [PMID: 10037299]
    • (1999) Am J Surg , vol.177 , pp. 2-6
    • Bakalakos, E.A.1    Burak, W.E.2    Young, D.C.3    Martin, E.W.4
  • 105
    • 7944226700 scopus 로고    scopus 로고
    • Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer
    • PMID: 15499601
    • Van Hazel G, Blackwell A, Anderson J, Price D, Moroz P, Bower G, Cardaci G, Gray B. Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer. J Surg Oncol 2004; 88: 78-85 [PMID: 15499601 DOI: 10.1002/jso.20141]
    • (2004) J Surg Oncol , vol.88 , pp. 78-85
    • Van Hazel, G.1    Blackwell, A.2    Anderson, J.3    Price, D.4    Moroz, P.5    Bower, G.6    Cardaci, G.7    Gray, B.8
  • 106
    • 0035700227 scopus 로고    scopus 로고
    • Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer
    • PMID: 11843249
    • Gray B, Van Hazel G, Hope M, Burton M, Moroz P, Anderson J, Gebski V. Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Ann Oncol 2001; 12: 1711-1720 [PMID: 11843249]
    • (2001) Ann Oncol , vol.12 , pp. 1711-1720
    • Gray, B.1    Van Hazel, G.2    Hope, M.3    Burton, M.4    Moroz, P.5    Anderson, J.6    Gebski, V.7
  • 107
    • 0029010380 scopus 로고
    • Resection versus resection combined with adjuvant pre- and post-operative chemotherapy - Immunotherapy for metastatic colorectal liver cancer. A new look at an old problem
    • PMID: 7672764
    • Lygidakis NJ, Ziras N, Parissis J. Resection versus resection combined with adjuvant pre- and post-operative chemotherapy - immunotherapy for metastatic colorectal liver cancer. A new look at an old problem. Hepatogastroenterology 1995; 42: 155-161 [PMID: 7672764]
    • (1995) Hepatogastroenterology , vol.42 , pp. 155-161
    • Lygidakis, N.J.1    Ziras, N.2    Parissis, J.3
  • 109
    • 0021914914 scopus 로고
    • Experience with continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal primaries. A prospective randomized study
    • PMID: 3971296
    • Kemeny MM, Goldberg DA, Browning S, Metter GE, Miner PJ, Terz JJ. Experience with continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal primaries. A prospective randomized study. Cancer 1985; 55: 1265-1270 [PMID: 3971296]
    • (1985) Cancer , vol.55 , pp. 1265-1270
    • Kemeny, M.M.1    Goldberg, D.A.2    Browning, S.3    Metter, G.E.4    Miner, P.J.5    Terz, J.J.6
  • 110
    • 0343729320 scopus 로고    scopus 로고
    • Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer
    • German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen) PMID: 9860474
    • Lorenz M, Müller HH, Schramm H, Gassel HJ, Rau HG, Ridwelski K, Hauss J, Stieger R, Jauch KW, Bechstein WO, Encke A. Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen) Ann Surg 1998; 228: 756-762 [PMID: 9860474]
    • (1998) Ann Surg , vol.228 , pp. 756-762
    • Lorenz, M.1    Müller, H.H.2    Schramm, H.3    Gassel, H.J.4    Rau, H.G.5    Ridwelski, K.6    Hauss, J.7    Stieger, R.8    Jauch, K.W.9    Bechstein, W.O.10    Encke, A.11
  • 111
    • 70249149719 scopus 로고    scopus 로고
    • Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma
    • PMID: 19470932
    • Kemeny NE, Melendez FD, Capanu M, Paty PB, Fong Y, Schwartz LH, Jarnagin WR, Patel D, D'Angelica M. Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma. J Clin Oncol 2009; 27: 3465-3471 [PMID: 19470932 DOI: 10.1200/JCO.2008.20.1301]
    • (2009) J Clin Oncol , vol.27 , pp. 3465-3471
    • Kemeny, N.E.1    Melendez, F.D.2    Capanu, M.3    Paty, P.B.4    Fong, Y.5    Schwartz, L.H.6    Jarnagin, W.R.7    Patel, D.8    D'Angelica, M.9
  • 112
    • 0037087721 scopus 로고    scopus 로고
    • Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: Surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy - An intergroup study
    • PMID: 11896097
    • Kemeny MM, Adak S, Gray B, Macdonald JS, Smith T, Lipsitz S, Sigurdson ER, O'Dwyer PJ, Benson AB. Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy - an intergroup study. J Clin Oncol 2002; 20: 1499-1505 [PMID: 11896097]
    • (2002) J Clin Oncol , vol.20 , pp. 1499-1505
    • Kemeny, M.M.1    Adak, S.2    Gray, B.3    Macdonald, J.S.4    Smith, T.5    Lipsitz, S.6    Sigurdson, E.R.7    O'Dwyer, P.J.8    Benson, A.B.9
  • 113
    • 84861566481 scopus 로고    scopus 로고
    • Hepatic arterial infusion and systemic chemotherapy after multiple metastasectomy in patients with colorectal carcinoma metastatic to the liver: A North Central Cancer Treatment Group (NCCTG) phase II study, 92-46-52
    • PMID: 21729678
    • Bolton JS, O'Connell MJ, Mahoney MR, Farr GH, Fitch TR, Maples WJ, Nagorney DM, Rubin J, Fuloria J, Steen PD, Alberts SR. Hepatic arterial infusion and systemic chemotherapy after multiple metastasectomy in patients with colorectal carcinoma metastatic to the liver: a North Central Cancer Treatment Group (NCCTG) phase II study, 92-46-52. Clin Colorectal Cancer 2012; 11: 31-37 [PMID: 21729678 DOI: 10.1016/j.clcc.2011.03.029]
    • (2012) Clin Colorectal Cancer , vol.11 , pp. 31-37
    • Bolton, J.S.1    O'Connell, M.J.2    Mahoney, M.R.3    Farr, G.H.4    Fitch, T.R.5    Maples, W.J.6    Nagorney, D.M.7    Rubin, J.8    Fuloria, J.9    Steen, P.D.10    Alberts, S.R.11
  • 114
    • 80051706635 scopus 로고    scopus 로고
    • Ablative therapies for colorectal liver metastases: A systematic review
    • PMID: 21689362
    • Pathak S, Jones R, Tang JM, Parmar C, Fenwick S, Malik H, Poston G. Ablative therapies for colorectal liver metastases: a systematic review. Colorectal Dis 2011; 13: e252-e265 [PMID: 21689362 DOI: 10.1111/j.1463-1318.2011.02695.x]
    • (2011) Colorectal Dis , vol.13 , pp. e252-e265
    • Pathak, S.1    Jones, R.2    Tang, J.M.3    Parmar, C.4    Fenwick, S.5    Malik, H.6    Poston, G.7
  • 116
    • 84857451140 scopus 로고    scopus 로고
    • Survival after lung metastasectomy in colorectal cancer patients with previously resected liver metastases
    • PMID: 22167262
    • Gonzalez M, Robert JH, Halkic N, Mentha G, Roth A, Perneger T, Ris HB, Gervaz P. Survival after lung metastasectomy in colorectal cancer patients with previously resected liver metastases. World J Surg 2012; 36: 386-391 [PMID: 22167262 DOI: 10.1007/s00268-011-1381-3]
    • (2012) World J Surg , vol.36 , pp. 386-391
    • Gonzalez, M.1    Robert, J.H.2    Halkic, N.3    Mentha, G.4    Roth, A.5    Perneger, T.6    Ris, H.B.7    Gervaz, P.8
  • 117
    • 84877876611 scopus 로고    scopus 로고
    • Long-term results and prognostic factors after resection of hepatic and pulmonary metastases of colorectal cancer
    • PMID: 22885838
    • Schüle S, Dittmar Y, Knösel T, Krieg P, Albrecht R, Settmacher U, Altendorf-Hofmann A. Long-term results and prognostic factors after resection of hepatic and pulmonary metastases of colorectal cancer. Int J Colorectal Dis 2013; 28: 537-545 [PMID: 22885838 DOI: 10.1007/s00384-012-1553-0]
    • (2013) Int J Colorectal Dis , vol.28 , pp. 537-545
    • Schüle, S.1    Dittmar, Y.2    Knösel, T.3    Krieg, P.4    Albrecht, R.5    Settmacher, U.6    Altendorf-Hofmann, A.7
  • 119
    • 4444375263 scopus 로고    scopus 로고
    • Retrospective study of resection of pulmonary metastases in patients with advanced colorectal cancer: The development of a preoperative chemotherapy strategy
    • PMID: 15285817
    • Negri F, Musolino A, Cunningham D, Pastorino U, Ladas G, Norman AR. Retrospective study of resection of pulmonary metastases in patients with advanced colorectal cancer: the development of a preoperative chemotherapy strategy. Clin Colorectal Cancer 2004; 4: 101-106 [PMID: 15285817]
    • (2004) Clin Colorectal Cancer , vol.4 , pp. 101-106
    • Negri, F.1    Musolino, A.2    Cunningham, D.3    Pastorino, U.4    Ladas, G.5    Norman, A.R.6
  • 121
    • 0023156451 scopus 로고
    • Patterns of failure following surgical resection of colorectal cancer liver metastases. Rationale for a multimodal approach
    • PMID: 3827362
    • Bozzetti F, Doci R, Bignami P, Morabito A, Gennari L. Patterns of failure following surgical resection of colorectal cancer liver metastases. Rationale for a multimodal approach. Ann Surg 1987; 205: 264-270 [PMID: 3827362]
    • (1987) Ann Surg , vol.205 , pp. 264-270
    • Bozzetti, F.1    Doci, R.2    Bignami, P.3    Morabito, A.4    Gennari, L.5
  • 122
    • 0025025345 scopus 로고
    • Tumor recurrence and options for further treatment after resection of liver metastases in patients with colorectal cancer
    • PMID: 2385101
    • Hohenberger P, Schlag P, Schwarz V, Herfarth C. Tumor recurrence and options for further treatment after resection of liver metastases in patients with colorectal cancer. J Surg Oncol 1990; 44: 245-251 [PMID: 2385101]
    • (1990) J Surg Oncol , vol.44 , pp. 245-251
    • Hohenberger, P.1    Schlag, P.2    Schwarz, V.3    Herfarth, C.4
  • 124
    • 84864659128 scopus 로고    scopus 로고
    • Different metastatic pattern according to the KRAS mutational status and site-specific discordance of KRAS status in patients with colorectal cancer
    • PMID: 22876814
    • Kim MJ, Lee HS, Kim JH, Kim YJ, Kwon JH, Lee JO, Bang SM, Park KU, Kim DW, Kang SB, Kim JS, Lee JS, Lee KW. Different metastatic pattern according to the KRAS mutational status and site-specific discordance of KRAS status in patients with colorectal cancer. BMC Cancer 2012; 12: 347 [PMID: 22876814 DOI: 10.1186/1471-2407-12-347]
    • (2012) BMC Cancer , vol.12 , pp. 347
    • Kim, M.J.1    Lee, H.S.2    Kim, J.H.3    Kim, Y.J.4    Kwon, J.H.5    Lee, J.O.6    Bang, S.M.7    Park, K.U.8    Kim, D.W.9    Kang, S.B.10    Kim, J.S.11    Lee, J.S.12    Lee, K.W.13
  • 125
    • 67349096282 scopus 로고    scopus 로고
    • How uncommon are isolated lung metastases in colorectal cancer? A review from database of 754 patients over 4 years
    • PMID: 19082673
    • Tan KK, Lopes Gde L, Sim R. How uncommon are isolated lung metastases in colorectal cancer? A review from database of 754 patients over 4 years. J Gastrointest Surg 2009; 13: 642-648 [PMID: 19082673 DOI: 10.1007/s11605-008-0757-7]
    • (2009) J Gastrointest Surg , vol.13 , pp. 642-648
    • Tan, K.K.1    Lopes Gde, L.2    Sim, R.3
  • 126
    • 0032748286 scopus 로고    scopus 로고
    • Surgical treatment for both pulmonary and hepatic metastases from colorectal cancer
    • PMID: 10595983
    • Kobayashi K, Kawamura M, Ishihara T. Surgical treatment for both pulmonary and hepatic metastases from colorectal cancer. J Thorac Cardiovasc Surg 1999; 118: 1090-1096 [PMID: 10595983]
    • (1999) J Thorac Cardiovasc Surg , vol.118 , pp. 1090-1096
    • Kobayashi, K.1    Kawamura, M.2    Ishihara, T.3
  • 128
    • 0028228367 scopus 로고
    • Survival benefit of repeat liver resections for recurrent colorectal metastases: 143 cases
    • Association Francaise de Chirurgie PMID: 8021741
    • Nordlinger B, Vaillant JC, Guiguet M, Balladur P, Paris F, Bachellier P, Jaeck D. Survival benefit of repeat liver resections for recurrent colorectal metastases: 143 cases. Association Francaise de Chirurgie. J Clin Oncol 1994; 12: 1491-1496 [PMID: 8021741]
    • (1994) J Clin Oncol , vol.12 , pp. 1491-1496
    • Nordlinger, B.1    Vaillant, J.C.2    Guiguet, M.3    Balladur, P.4    Paris, F.5    Bachellier, P.6    Jaeck, D.7
  • 130
    • 0034055872 scopus 로고    scopus 로고
    • Aggressive surgical approach to recurrent tumors after hepatectomy for metastatic spread of colorectal cancer to the liver
    • PMID: 10819061
    • Imamura H, Kawasaki S, Miyagawa S, Ikegami T, Kitamura H, Shimada R. Aggressive surgical approach to recurrent tumors after hepatectomy for metastatic spread of colorectal cancer to the liver. Surgery 2000; 127: 528-535 [PMID: 10819061]
    • (2000) Surgery , vol.127 , pp. 528-535
    • Imamura, H.1    Kawasaki, S.2    Miyagawa, S.3    Ikegami, T.4    Kitamura, H.5    Shimada, R.6
  • 131
    • 0036106783 scopus 로고    scopus 로고
    • Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: A bi-institutional analysis
    • PMID: 12035044
    • Petrowsky H, Gonen M, Jarnagin W, Lorenz M, DeMatteo R, Heinrich S, Encke A, Blumgart L, Fong Y. Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi-institutional analysis. Ann Surg 2002; 235: 863-871 [PMID: 12035044]
    • (2002) Ann Surg , vol.235 , pp. 863-871
    • Petrowsky, H.1    Gonen, M.2    Jarnagin, W.3    Lorenz, M.4    DeMatteo, R.5    Heinrich, S.6    Encke, A.7    Blumgart, L.8    Fong, Y.9
  • 132
    • 0036479981 scopus 로고    scopus 로고
    • Multiple repeat resections of intra- and extrahepatic recurrences in patients undergoing initial hepatectomy for colorectal carcinoma metastases
    • PMID: 11865339
    • Nagakura S, Shirai Y, Suda T, Hatakeyama K. Multiple repeat resections of intra- and extrahepatic recurrences in patients undergoing initial hepatectomy for colorectal carcinoma metastases. World J Surg 2002; 26: 141-147 [PMID: 11865339 DOI: 10.1007/s00268-001-0196-z]
    • (2002) World J Surg , vol.26 , pp. 141-147
    • Nagakura, S.1    Shirai, Y.2    Suda, T.3    Hatakeyama, K.4
  • 133
    • 2442716278 scopus 로고    scopus 로고
    • Procedures of choice for resection of primary and recurrent liver metastases from colorectal cancer
    • PMID: 15085394
    • Tanaka K, Shimada H, Ohta M, Togo S, Saitou S, Yamaguchi S, Endo I, Sekido H. Procedures of choice for resection of primary and recurrent liver metastases from colorectal cancer. World J Surg 2004; 28: 482-487 [PMID: 15085394 DOI: 10.1007/s00268-004-7214-x]
    • (2004) World J Surg , vol.28 , pp. 482-487
    • Tanaka, K.1    Shimada, H.2    Ohta, M.3    Togo, S.4    Saitou, S.5    Yamaguchi, S.6    Endo, I.7    Sekido, H.8
  • 136
    • 37349009576 scopus 로고    scopus 로고
    • A second liver resection due to recurrent colorectal liver metastases
    • discussion 1150 PMID: 18086980
    • Sa Cunha A, Laurent C, Rault A, Couderc P, Rullier E, Saric J. A second liver resection due to recurrent colorectal liver metastases. Arch Surg 2007; 142: 1144-1149; discussion 1150 [PMID: 18086980 DOI: 10.1001/archsurg.142.12.1144]
    • (2007) Arch Surg , vol.142 , pp. 1144-1149
    • Sa Cunha, A.1    Laurent, C.2    Rault, A.3    Couderc, P.4    Rullier, E.5    Saric, J.6
  • 140
    • 0025312728 scopus 로고
    • A genetic model for colorectal tumorigenesis
    • PMID: 2188735
    • Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-767 [PMID: 2188735]
    • (1990) Cell , vol.61 , pp. 759-767
    • Fearon, E.R.1    Vogelstein, B.2
  • 141
    • 79751489596 scopus 로고    scopus 로고
    • Molecular genetics of colorectal cancer
    • PMID: 21090969
    • Fearon ER . Molecular genetics of colorectal cancer. Annu Rev Pathol 2011; 6: 479-507 [PMID: 21090969 DOI: 10.1146/annurev-pathol-011110-130235]
    • (2011) Annu Rev Pathol , vol.6 , pp. 479-507
    • Fearon, E.R.1
  • 144
    • 77950521000 scopus 로고    scopus 로고
    • Mismatch repair deficient colorectal cancer in the era of personalized treatment
    • PMID: 20177404
    • Hewish M, Lord CJ, Martin SA, Cunningham D, Ashworth A. Mismatch repair deficient colorectal cancer in the era of personalized treatment. Nat Rev Clin Oncol 2010; 7: 197-208 [PMID: 20177404 DOI: 10.1038/nrclinonc.2010.18]
    • (2010) Nat Rev Clin Oncol , vol.7 , pp. 197-208
    • Hewish, M.1    Lord, C.J.2    Martin, S.A.3    Cunningham, D.4    Ashworth, A.5
  • 145
    • 84863922124 scopus 로고    scopus 로고
    • Comprehensive molecular characterization of human colon and rectal cancer
    • PMID: 22810696
    • Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012; 487: 330-337 [PMID: 22810696 DOI: 10.1038/nature11252]
    • (2012) Nature , vol.487 , pp. 330-337
    • Cancer Genome Atlas Network1
  • 146
    • 84858005794 scopus 로고    scopus 로고
    • Tumour heterogeneity and drug resistance: Personalising cancer medicine through functional genomics
    • PMID: 22192819
    • Lee AJ, Swanton C. Tumour heterogeneity and drug resistance: personalising cancer medicine through functional genomics. Biochem Pharmacol 2012; 83: 1013-1020 [PMID: 22192819 DOI: 10.1016/j.bcp.2011.12.008]
    • (2012) Biochem Pharmacol , vol.83 , pp. 1013-1020
    • Lee, A.J.1    Swanton, C.2
  • 150
    • 79959838081 scopus 로고    scopus 로고
    • Integrated genomic analyses of ovarian carcinoma
    • PMID: 21720365
    • Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature 2011; 474: 609-615 [PMID: 21720365 DOI: 10.1038/nature10166]
    • (2011) Nature , vol.474 , pp. 609-615
    • Cancer Genome Atlas Research Network1
  • 152
    • 76049098292 scopus 로고    scopus 로고
    • Prevalence and heterogeneity of KRAS, BRAF, and PIK3CA mutations in primary colorectal adenocarcinomas and their corresponding metastases
    • PMID: 20103678
    • Baldus SE, Schaefer KL, Engers R, Hartleb D, Stoecklein NH, Gabbert HE. Prevalence and heterogeneity of KRAS, BRAF, and PIK3CA mutations in primary colorectal adenocarcinomas and their corresponding metastases. Clin Cancer Res 2010; 16: 790-799 [PMID: 20103678 DOI: 10.1158/1078-0432.CCR-09-2446]
    • (2010) Clin Cancer Res , vol.16 , pp. 790-799
    • Baldus, S.E.1    Schaefer, K.L.2    Engers, R.3    Hartleb, D.4    Stoecklein, N.H.5    Gabbert, H.E.6
  • 153
    • 80053198693 scopus 로고    scopus 로고
    • Concordance of predictive markers for EGFR inhibitors in primary tumors and metastases in colorectal cancer: A review
    • PMID: 21742964
    • Baas JM, Krens LL, Guchelaar HJ, Morreau H, Gelderblom H. Concordance of predictive markers for EGFR inhibitors in primary tumors and metastases in colorectal cancer: a review. Oncologist 2011; 16: 1239-1249 [PMID: 21742964 DOI: 10.1634/theoncologist.2011-0024]
    • (2011) Oncologist , vol.16 , pp. 1239-1249
    • Baas, J.M.1    Krens, L.L.2    Guchelaar, H.J.3    Morreau, H.4    Gelderblom, H.5
  • 155
    • 84861539889 scopus 로고    scopus 로고
    • An update on the current and emerging targeted agents in metastatic colorectal cancer
    • PMID: 21752724
    • Chu E . An update on the current and emerging targeted agents in metastatic colorectal cancer. Clin Colorectal Cancer 2012; 11: 1-13 [PMID: 21752724 DOI: 10.1016/j.clcc.2011.05.005]
    • (2012) Clin Colorectal Cancer , vol.11 , pp. 1-13
    • Chu, E.1
  • 159
    • 84877244768 scopus 로고    scopus 로고
    • Targeting the PI3K-AKT-mTOR signaling network in cancer
    • PMID: 23642907
    • Khan KH, Yap TA, Yan L, Cunningham D. Targeting the PI3K-AKT-mTOR signaling network in cancer. Chin J Cancer 2013; 32: 253-265 [PMID: 23642907 DOI: 10.5732/cjc.013.10057]
    • (2013) Chin J Cancer , vol.32 , pp. 253-265
    • Khan, K.H.1    Yap, T.A.2    Yan, L.3    Cunningham, D.4
  • 160
    • 84876541026 scopus 로고    scopus 로고
    • Development of therapeutic combinations targeting major cancer signaling pathways
    • PMID: 23509311
    • Yap TA, Omlin A, de Bono JS. Development of therapeutic combinations targeting major cancer signaling pathways. J Clin Oncol 2013; 31: 1592-1605 [PMID: 23509311 DOI: 10.1200/JCO.2011.37.6418]
    • (2013) J Clin Oncol , vol.31 , pp. 1592-1605
    • Yap, T.A.1    Omlin, A.2    De Bono, J.S.3
  • 161
    • 84882982114 scopus 로고    scopus 로고
    • Novel drug discovery opportunities for colorectal cancer
    • PMID: 23768167
    • Curtin JC. Novel drug discovery opportunities for colorectal cancer. Expert Opin Drug Discov 2013; 8: 1153-1164 [PMID: 23768167 DOI: 10.1517/17460441.2013.807249]
    • (2013) Expert Opin Drug Discov , vol.8 , pp. 1153-1164
    • Curtin, J.C.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.